Classified by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) as a steriles supersite licensed to produce sterile antibiotics. 

The building designed by DPDS Architecture represents a highly contemporary solution housing the specialist manufacturing process.  DPDS’s planning team prepared and submitted the planning application along with the Environmental Statement dealing with a range of flood risk, air quality, noise, landscape and ecological issues.

The facility will be at the forefront of pharmaceutical technology, delivering new drugs that are demanded to counter antibiotic-resisting bacterium such as MRSA.